Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max S Mano

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|March 26, 2021
Integrating Adjuvant Radiation with Post-Neoadjuvant Therapies in Early Breast CancerMax S Mano, Leandro Jonata C Oliveira, Samir A Hanna
Rare Tumors|December 9, 2010
Rare tumors research in emerging countriesMax S Mano, Roberto J Arai, Paulo M G Hoff
Biomarker Research|June 28, 2018
Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapyRoberto J Arai, Vanessa Petry, Paulo M Hoff, et al.
Cancer Treatment Reviews|October 2, 2007
Novel cytotoxic drugs: old challenges, new solutionsGustavo F V Ismael, Daniela Dornelles Rosa, Max S Mano, et al.
Cancer Treatment Reviews|November 23, 2006
The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumoursMax S Mano, Daniela D Rosa, Evandro De Azambuja, et al.
Breast (Edinburgh, Scotland)|February 14, 2006
Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapyMax S Mano, Ghislaine Fraser, Janet Kerr, et al.
Breast (Edinburgh, Scotland)|October 23, 2013
Biological therapies in breast cancer: common toxicities and management strategiesRomualdo Barroso-Sousa, Iuri A Santana, Laura Testa, et al.
Breast (Edinburgh, Scotland)|September 10, 2020
The impact on clinical outcomes of post-operative radiation therapy delay after neoadjuvant chemotherapy in patients with breast cancer: A multicentric international studyGustavo Nader Marta, Reem AlBeesh, Allan A Lima Pereira, et al.
Archives of Gynecology and Obstetrics|February 15, 2008
Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinomaDaniela D Rosa, Ahmad Awada, Max S Mano, et al.
Critical Reviews in Oncology/Hematology|May 17, 2022
Gene expression signatures in early breast cancer: Better together with clinicopathological featuresLeandro Jonata Carvalho Oliveira, Larissa Costa Amorim, Thais Baccili Cury Megid, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|March 26, 2021
Integrating Adjuvant Radiation with Post-Neoadjuvant Therapies in Early Breast CancerMax S Mano, Leandro Jonata C Oliveira, Samir A Hanna
Rare Tumors|December 9, 2010
Rare tumors research in emerging countriesMax S Mano, Roberto J Arai, Paulo M G Hoff
Biomarker Research|June 28, 2018
Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapyRoberto J Arai, Vanessa Petry, Paulo M Hoff, et al.
Cancer Treatment Reviews|October 2, 2007
Novel cytotoxic drugs: old challenges, new solutionsGustavo F V Ismael, Daniela Dornelles Rosa, Max S Mano, et al.
Cancer Treatment Reviews|November 23, 2006
The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumoursMax S Mano, Daniela D Rosa, Evandro De Azambuja, et al.
Breast (Edinburgh, Scotland)|February 14, 2006
Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapyMax S Mano, Ghislaine Fraser, Janet Kerr, et al.
Breast (Edinburgh, Scotland)|October 23, 2013
Biological therapies in breast cancer: common toxicities and management strategiesRomualdo Barroso-Sousa, Iuri A Santana, Laura Testa, et al.
Breast (Edinburgh, Scotland)|September 10, 2020
The impact on clinical outcomes of post-operative radiation therapy delay after neoadjuvant chemotherapy in patients with breast cancer: A multicentric international studyGustavo Nader Marta, Reem AlBeesh, Allan A Lima Pereira, et al.
Archives of Gynecology and Obstetrics|February 15, 2008
Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinomaDaniela D Rosa, Ahmad Awada, Max S Mano, et al.
Critical Reviews in Oncology/Hematology|May 17, 2022
Gene expression signatures in early breast cancer: Better together with clinicopathological featuresLeandro Jonata Carvalho Oliveira, Larissa Costa Amorim, Thais Baccili Cury Megid, et al.
Pageof 5